Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/1998
08/27/1998WO1998013031A3 Medicinal aerosol formulations comprising budesonide
08/27/1998DE19716905C1 Aqueous L-selegilin solution for treating Parkinson's disease
08/27/1998DE19706979A1 Kombinationspräparat für oral applizierbare Erythromycine Combined preparation for orally administered erythromycin
08/27/1998DE19706978A1 Kombinationspräparat für oral applizierbare Antibiotika Combined preparation for orally administered antibiotics
08/27/1998DE19705538C1 Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen A process for the separation of active ingredients in solid pharmaceutical preparations
08/27/1998CA2281919A1 Gel delivery vehicles for anticellular proliferative agents
08/27/1998CA2281873A1 Process for preparing aromatic polyamine mixtures
08/27/1998CA2281799A1 Methods and compositions for the protection of mitochondria
08/27/1998CA2281493A1 Site-specific drug delivery
08/27/1998CA2276339A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
08/26/1998EP0860211A1 Ultrasonic nebulizing
08/26/1998EP0860170A1 Isotopic urea tablets
08/26/1998EP0860169A2 Compositions for oral administration containing pyridazinone compounds
08/26/1998EP0860167A1 RNA-and DNA- based active agents in nanoparticles
08/26/1998EP0860166A1 Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms
08/26/1998EP0859804A1 Water-soluble or water-dispersible polyurethanes with terminal acid groups, the production and the use thereof
08/26/1998EP0859751A1 Semi-fluorinated alkanes and their use
08/26/1998EP0859636A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization
08/26/1998EP0859634A1 Pharmaceutical compositions containing platelet aggregation inhibitors
08/26/1998EP0859626A1 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing the said preparation
08/26/1998EP0859623A1 Absorbable prophylactic composition for protection against ionising or non-ionising electromagnetic waves
08/26/1998EP0859622A1 Extracts of shark cartilage
08/26/1998EP0859616A1 Topical composition containing capsazepine
08/26/1998EP0859612A2 Novel composition containing an acid-labile omeprazole and process for its preparation
08/26/1998EP0859609A1 Topical liquid composition, method for preparing same and uses thereof
08/26/1998EP0859606A1 Buccal delivery of glucagon-like insulinotropic peptides
08/26/1998EP0859605A1 Transdermal therapeutic system (tts) for administering active substances for the treatment of drug dependency or drug addiction
08/26/1998EP0859604A1 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
08/26/1998EP0859603A1 Sustained release matrix for high-dose insoluble drugs
08/26/1998EP0859602A1 Method of producing medicaments in solid form
08/26/1998EP0859601A2 Prolonged release of gm-csf
08/26/1998EP0859600A1 New technology for wet granulation
08/26/1998EP0859599A1 Liposomal formulations of mitoxantrone
08/26/1998EP0859598A1 Liposomes containing a corticosteroid
08/26/1998EP0859597A1 Sustained release delivery system and long acting narcotic analgesics and antagonists
08/26/1998EP0859596A2 Gel formulations containing growth factors
08/26/1998EP0859595A1 Therapeutic preparation for the transdermal administration of active substances
08/26/1998EP0859554A1 Aromatic granulated material
08/26/1998EP0653938B1 Topical composition
08/26/1998CN1191553A Method of detecting lung disease
08/26/1998CN1191546A Polymerized microemulsion pressure-sensitive adhesive compositions and method of preparing and using same
08/26/1998CN1191545A Process of high purity albumin production
08/26/1998CN1191492A Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
08/26/1998CN1191480A Soft gelatin capsules contg. particulate material
08/26/1998CN1191475A Drug delivery compositions for improved stability of steroids
08/26/1998CN1191139A Liquid gonadotropin containing formulations
08/26/1998CN1191128A Anti-nicotine lung-protecting liquid and its producing method
08/26/1998CN1191127A 'Anzhihua'ai' liquid for cancer and its producing method
08/26/1998CN1191115A Analgesic injection and its preparing method
08/26/1998CN1191112A Skin protecting antichapping cream
08/26/1998CN1191110A Process and apparatus for producing cyclodextrin molecular microcapsule composition
08/26/1998CN1039570C Preparation method of artificial mucus for lubricating body cavity
08/25/1998US5798391 Viricides, antitubercular agents
08/25/1998US5798347 Dehydroepiandrosterone and dehydroepiandrosterone sulfate used for inhibiting proliferation of ovarian cancer
08/25/1998US5798252 Shell of microbial cell wall having dye adsorbed on surface encapsulating essential oil flavoring or fragrance
08/25/1998US5798225 Process for recombinant production of PTH and PTHrp analogs
08/25/1998US5798120 Enteric granule-containing tablets
08/25/1998US5798119 Osmotic-delivery devices having vapor-permeable coatings
08/25/1998US5798115 Biocompatible polymer comprising an active drug on polymer backbone; biodegradable, releasing the drug
08/25/1998US5798114 Implantable, refillable dispensing device for delivering drug to body, including septum means for facilitating introduction of drug to first chamber and removal of delivery fluid from second chamber
08/25/1998US5798113 Grafting a vehicle containing core which contains isolated cells, either suspended in liquid or immobilized within hydrogel matrix, surrounded by a biocompatible jacket which protects isolated cells in core from immunological attack
08/25/1998US5798093 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith
08/25/1998US5798091 Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
08/25/1998US5798042 Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters
08/25/1998US5797898 For the release of molecules
08/25/1998US5797874 Method of delivery of gas-supersaturated liquids
08/25/1998CA2137677C Stabilized somatotropin for parenteral administration
08/25/1998CA2122479C Risedronate delayed-release compositions
08/25/1998CA2122478C Unit dose form of bismuth subsalicylate
08/25/1998CA2117588C Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
08/25/1998CA2107620C Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic
08/25/1998CA2030551C Process for producing small particles of biologically active molecules
08/20/1998WO1998036013A1 Monomers derived from hydroxy acids and polymers prepared therefrom
08/20/1998WO1998035992A1 Manufacture of cross-linked amylose useful as an excipient for control release of active compounds
08/20/1998WO1998035709A1 Method and composition for coating wound or protecting animal skin
08/20/1998WO1998035704A1 Targeted therapeutic delivery of vitamin d compounds
08/20/1998WO1998035700A1 Composition with base of coconut oil and its use
08/20/1998WO1998035688A1 Method for destroying retinal pigment epithelial cells
08/20/1998WO1998035682A1 Agent for hormonal contraception and/or treatment and/or prophylaxis of mammary glands with three hormone components
08/20/1998WO1998035681A1 Oxacarbazepine film-coated tablets
08/20/1998WO1998035672A1 Pharmaceutical formulations comprising amoxocyllin and clavulanate
08/20/1998WO1998035669A1 Methods for administering nutritional indium
08/20/1998WO1998035666A1 Formulations of nanoparticle naproxen tablets
08/20/1998WO1998035663A1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound
08/20/1998WO1998035662A1 Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium
08/20/1998WO1998035660A1 Transdermal, oral and intravenous preparations of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
08/20/1998WO1998035657A1 New delivery system for administering dentin-hypersensitivity-ameliorating compositions
08/20/1998WO1998035656A1 Process for preparing solid pharmaceutical dosage forms
08/20/1998WO1998035655A2 Method for separating active substances in solid pharmaceutical preparations
08/20/1998WO1998035654A1 Continuous microsphere process
08/20/1998WO1998035653A1 Implantable collagen-containing putty material
08/20/1998WO1998035651A1 Spray compositions
08/20/1998WO1998035650A1 Spray compositions
08/20/1998WO1998035631A1 Biocompatible polymers and methods for their use
08/20/1998WO1998024410A3 Controlled release matrix tablet and method for its preparation
08/20/1998WO1998022136A3 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies
08/20/1998WO1998020860A3 Hydrocolloid delivery system
08/20/1998WO1998019708A3 Method for enhancing the solubility of substantially water-insoluble compounds
08/20/1998WO1998017284A3 Inhibition of cap-independent protein synthesis and hiv-tar translation by heparin or heparin mimetics, and methods for gene therapy
08/20/1998DE3790355C2 Prodn. of preparations of high gastric acid binding capacity
1 ... 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 2607 ... 2991